BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7365463)

  • 1. Location of post-translational cleavage events within F and HN glycoproteins of Newcastle disease virus.
    Samson AC; Chambers P; Dickinson JH
    J Gen Virol; 1980 Mar; 47(1):19-27. PubMed ID: 7365463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of pathotype-specific structural features and cleavage activation of Newcastle disease virus membrane glycoproteins using antipeptide antibodies.
    Hodder AN; Selleck PW; White JR; Gorman JJ
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1081-91. PubMed ID: 8509761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new structural protein for Newcastle disease virus.
    Chambers P; Samson AC
    J Gen Virol; 1980 Sep; 50(1):155-66. PubMed ID: 7441211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maturation of the hemagglutinin-neuraminidase and fusion glycoproteins of two biologically distinct strains of Newcastle disease virus.
    Smith GW; Schwalbe JC; Hightower LE
    Prog Clin Biol Res; 1980; 40():275-91. PubMed ID: 7454726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic activation of the haemagglutinin-neuraminidase of Newcastle disease virus involves loss of a glycopeptide.
    Garten W; Kohama T; Klenk HD
    J Gen Virol; 1980 Nov; 51(Pt 1):207-11. PubMed ID: 7463006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antigenic properties of NDV glycoproteins synthesized in the presence of 2-deoxy-d-glucose].
    Vasileva L; Neĭcheva I
    Vet Med Nauki; 1986; 23(5):29-36. PubMed ID: 3765372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-structural proteins in Newcastle disease virus-infected cells.
    Chambers P; Samson AC
    J Gen Virol; 1982 Jan; 58 Pt 1():1-12. PubMed ID: 7142963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide sequence of the gene encoding the fusion glycoprotein of Newcastle disease virus.
    Chambers P; Millar NS; Emmerson PT
    J Gen Virol; 1986 Dec; 67 ( Pt 12)():2685-94. PubMed ID: 3025345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipeptide antibodies for analysis of pathotype-specific variations in cleavage activation of the membrane glycoprotein precursors of Newcastle disease virus isolates in cultured cells.
    Gorman JJ; Hodder AN; Selleck PW; Hansson E
    J Virol Methods; 1992 Apr; 37(1):55-70. PubMed ID: 1572931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage.
    Anderson K; Stott EJ; Wertz GW
    J Gen Virol; 1992 May; 73 ( Pt 5)():1177-88. PubMed ID: 1375280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation of the envelope glycoproteins of Newcastle disease virus on cellular membranes.
    Schwalbe JC; Hightower LE
    J Virol; 1982 Mar; 41(3):947-57. PubMed ID: 6284983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide sequence of the fusion and haemagglutinin-neuraminidase glycoprotein genes of Newcastle disease virus, strain Ulster: molecular basis for variations in pathogenicity between strains.
    Millar NS; Chambers P; Emmerson PT
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():613-20. PubMed ID: 3351479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A temperature-sensitive mutant of Newcastle disease virus which is affected in both haemagglutinin-neuraminidase and matrix proteins.
    Harper DR; Samson AC; Lee CM; Simon E
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2781-4. PubMed ID: 6663286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of labile Newcastle disease virus progeny after infection of chicken embryo cells in the presence of caffeine.
    Olson NJ; Consigli RA
    Am J Vet Res; 1979 Mar; 40(3):387-92. PubMed ID: 573077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, stability, and cleavage of Newcastle disease virus glycoproteins in the absence of glycosylation.
    Morrison TG; Simpson D
    J Virol; 1980 Oct; 36(1):171-80. PubMed ID: 7441820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning of complementary DNA to Newcastle disease virus, and nucleotide sequence analysis of the junction between the genes encoding the haemagglutinin-neuraminidase and the large protein.
    Chambers P; Millar NS; Bingham RW; Emmerson PT
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():475-86. PubMed ID: 3754000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of pathotype-specific epitopes of newcastle disease virus fusion glycoproteins by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and post-source decay sequencing.
    Lopaticki S; Morrow CJ; Gorman JJ
    J Mass Spectrom; 1998 Oct; 33(10):950-60. PubMed ID: 9821327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid modification of Newcastle disease virus glycoproteins.
    Chatis PA; Morrison TG
    J Virol; 1982 Jul; 43(1):342-7. PubMed ID: 7109029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfide bonds in Sendai virus glycoproteins.
    Hardwick JM; Bussell RH
    Intervirology; 1979; 11(5):300-6. PubMed ID: 222708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amino acid substitutions on glycosylation of the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus strain Beaudette C.
    Yusoff K; Nesbit M; Samson AC; Emmerson PT
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1549-52. PubMed ID: 2471815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.